EnVVeno Medical Corporation
NVNO
Rang in aandelen
#40245
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Aandeelprijs
$10.71
Laatst gesynchroniseerd: 2026-07-31
Marktkapitalisatie
$176.75K
Verandering (1 dag)
0.79%
Verandering (1 jaar)
169,900.00%
Land
US
Handel EnVVeno Medical Corporation (NVNO)
Categorie
Healthcare
Marktkapitalisatie van EnVVeno Medical Corporation(NVNO)
Marktkapitalisatie: $176.75K
Vanaf October 2026 heeft EnVVeno Medical Corporation een marktkapitalisatie van $176.75K. Dit maakt EnVVeno Medical Corporation volgens onze gegevens het 40245th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van EnVVeno Medical Corporation van 2018 tot 2026
NVNO vergeleken met de top 5 populairste stocks
| Prijs voor NVNO | Aandeel B | Marktkapitalisatie van B | uitslagen | |
|---|---|---|---|---|
$393,979,413
$82.63
|
$5.167T | +6,253,641,474,281.09% | ||
|
$382,369,742
$82.63
|
$5.015T | +6,069,360,977,213.03% | ||
|
$313,259,796
$82.63
|
$4.108T | +4,972,377,717,332.48% | ||
|
$297,514,583
$82.63
|
$3.902T | +4,722,453,701,283.97% | ||
|
$205,067,178
$82.63
|
$2.689T | +3,255,034,574,390.62% |
